Authors: Gabrielle Gimenes Lima and Anderson Rossatto (FEBRAF, Brazil).
Although both the National Medicines Policy (PNM) and the National
Pharmaceutical Assistance Policy (PNAF) demonstrate the strategic importance
of the three major axes - of ensuring the safety, efficacy and quality of
medicines; promoting its rational use; the population's access to those
medicines considered essential - for many managers the concept of
Pharmaceutical Assistance still remains centered on the binomial acquisition
and distribution of medicines. There is still a need for a broader discussion on
the role and attributions of the state sphere, as an instance of coordination and
Only actions that have the necessary means for their execution will be feasible.
Political power is indispensable for building the viability of these conceptions.
The changes will only reach their improvement objectives when there is a real
interest that occurs, in the perspective of an ongoing process and not a one-off
event. We must not forget that the implementation of any strategy / action must
be understood as a process, with the involvement of everyone in its
construction and not only in the results. 2
The challenge of Pharmaceutical Assistance is, also at the state level, to
improve the population's access to medicines, to guarantee quality, safety and
efficacy, promoting its rational use.3
- ALBUQUERQUE, R. B.; CORDEIRO, M.; LINS, A. C. V.; NEIVA, J. S. M.;
ROCHA, M. S. Parecer n.1300/2006-AGU/CONJUR-MS/JSMN. Parecer de
consolidação da Assistência Farmacêutica, 2006.
- BELTRAME, A. Ampliação do acesso a medicamentos de alto custo: uma
análise da política brasileira. Rio de Janeiro, 2002. Dissertação (Mestrado em
Administração de Saúde) - de Pós-graduação em Saúde Coletiva , Instituto de
Medicina Social , Universidade do Estado do Rio de Janeiro.
- DANTAS, N. S.; GAVRONSKI A. A.; SILVA, O. J. B.; SILVA, R. R.,
elaboradores. Manual de atuação do Ministério Público Federal em defesa do
direito à saúde. 2005. Disponível em: http://pfde.pgr.mpf.gov.br